nodes	percent_of_prediction	percent_of_DWPC	metapath
Lovastatin—Antinuclear antibody positive—Ramipril—type 1 diabetes mellitus	0.047	0.119	CcSEcCtD
Lovastatin—PON3—islet of Langerhans—type 1 diabetes mellitus	0.0199	0.0966	CbGeAlD
Lovastatin—Hepatic necrosis—Ramipril—type 1 diabetes mellitus	0.0183	0.0467	CcSEcCtD
Lovastatin—ITGAL—cardiovascular system—type 1 diabetes mellitus	0.0147	0.0712	CbGeAlD
Lovastatin—PON3—pancreas—type 1 diabetes mellitus	0.014	0.0679	CbGeAlD
Lovastatin—ITGAL—lymphoid tissue—type 1 diabetes mellitus	0.0123	0.0598	CbGeAlD
Lovastatin—Jaundice cholestatic—Ramipril—type 1 diabetes mellitus	0.0121	0.0309	CcSEcCtD
Lovastatin—Vasculitis—Ramipril—type 1 diabetes mellitus	0.0109	0.0278	CcSEcCtD
Lovastatin—Gynaecomastia—Ramipril—type 1 diabetes mellitus	0.00954	0.0243	CcSEcCtD
Lovastatin—Photosensitivity—Ramipril—type 1 diabetes mellitus	0.00881	0.0224	CcSEcCtD
Lovastatin—Vascular purpura—Ramipril—type 1 diabetes mellitus	0.00865	0.022	CcSEcCtD
Lovastatin—Hepatic failure—Ramipril—type 1 diabetes mellitus	0.00861	0.0219	CcSEcCtD
Lovastatin—Haemolytic anaemia—Ramipril—type 1 diabetes mellitus	0.00857	0.0218	CcSEcCtD
Lovastatin—Amnesia—Ramipril—type 1 diabetes mellitus	0.00824	0.021	CcSEcCtD
Lovastatin—HDAC2—islet of Langerhans—type 1 diabetes mellitus	0.00812	0.0394	CbGeAlD
Lovastatin—Purpura—Ramipril—type 1 diabetes mellitus	0.00803	0.0204	CcSEcCtD
Lovastatin—Arthritis—Ramipril—type 1 diabetes mellitus	0.00796	0.0203	CcSEcCtD
Lovastatin—HMGCR—islet of Langerhans—type 1 diabetes mellitus	0.00733	0.0355	CbGeAlD
Lovastatin—UGT2B7—kidney—type 1 diabetes mellitus	0.00702	0.034	CbGeAlD
Lovastatin—CYP3A7-CYP3A51P—nephron tubule—type 1 diabetes mellitus	0.00701	0.034	CbGeAlD
Lovastatin—Cramp muscle—Ramipril—type 1 diabetes mellitus	0.00697	0.0177	CcSEcCtD
Lovastatin—Toxic epidermal necrolysis—Ramipril—type 1 diabetes mellitus	0.00697	0.0177	CcSEcCtD
Lovastatin—HDAC2—retina—type 1 diabetes mellitus	0.00694	0.0337	CbGeAlD
Lovastatin—Influenza—Ramipril—type 1 diabetes mellitus	0.00669	0.017	CcSEcCtD
Lovastatin—Eosinophilia—Ramipril—type 1 diabetes mellitus	0.00662	0.0168	CcSEcCtD
Lovastatin—Pancreatitis—Ramipril—type 1 diabetes mellitus	0.00656	0.0167	CcSEcCtD
Lovastatin—HDAC2—nephron tubule—type 1 diabetes mellitus	0.00654	0.0317	CbGeAlD
Lovastatin—Abdominal discomfort—Ramipril—type 1 diabetes mellitus	0.00641	0.0163	CcSEcCtD
Lovastatin—Erectile dysfunction—Ramipril—type 1 diabetes mellitus	0.00616	0.0157	CcSEcCtD
Lovastatin—Photosensitivity reaction—Ramipril—type 1 diabetes mellitus	0.0061	0.0155	CcSEcCtD
Lovastatin—UGT1A1—kidney—type 1 diabetes mellitus	0.00597	0.0289	CbGeAlD
Lovastatin—Stevens-Johnson syndrome—Ramipril—type 1 diabetes mellitus	0.00591	0.015	CcSEcCtD
Lovastatin—HMGCR—nephron tubule—type 1 diabetes mellitus	0.0059	0.0286	CbGeAlD
Lovastatin—HDAC2—cardiovascular system—type 1 diabetes mellitus	0.00587	0.0285	CbGeAlD
Lovastatin—Neuropathy peripheral—Ramipril—type 1 diabetes mellitus	0.00585	0.0149	CcSEcCtD
Lovastatin—Urinary tract infection—Ramipril—type 1 diabetes mellitus	0.0058	0.0147	CcSEcCtD
Lovastatin—HDAC2—kidney—type 1 diabetes mellitus	0.00575	0.0279	CbGeAlD
Lovastatin—HDAC2—pancreas—type 1 diabetes mellitus	0.00571	0.0277	CbGeAlD
Lovastatin—Sinusitis—Ramipril—type 1 diabetes mellitus	0.00559	0.0142	CcSEcCtD
Lovastatin—Hepatitis—Ramipril—type 1 diabetes mellitus	0.00535	0.0136	CcSEcCtD
Lovastatin—HMGCR—cardiovascular system—type 1 diabetes mellitus	0.0053	0.0257	CbGeAlD
Lovastatin—HMGCR—kidney—type 1 diabetes mellitus	0.00518	0.0251	CbGeAlD
Lovastatin—HMGCR—pancreas—type 1 diabetes mellitus	0.00515	0.025	CbGeAlD
Lovastatin—Erythema multiforme—Ramipril—type 1 diabetes mellitus	0.00506	0.0129	CcSEcCtD
Lovastatin—Flushing—Ramipril—type 1 diabetes mellitus	0.00497	0.0126	CcSEcCtD
Lovastatin—SLCO1B1—kidney—type 1 diabetes mellitus	0.00497	0.0241	CbGeAlD
Lovastatin—HDAC2—lymphoid tissue—type 1 diabetes mellitus	0.00493	0.0239	CbGeAlD
Lovastatin—Alopecia—Ramipril—type 1 diabetes mellitus	0.00473	0.012	CcSEcCtD
Lovastatin—Dysgeusia—Ramipril—type 1 diabetes mellitus	0.00456	0.0116	CcSEcCtD
Lovastatin—Muscle spasms—Ramipril—type 1 diabetes mellitus	0.00448	0.0114	CcSEcCtD
Lovastatin—HMGCR—lymphoid tissue—type 1 diabetes mellitus	0.00445	0.0216	CbGeAlD
Lovastatin—Tremor—Ramipril—type 1 diabetes mellitus	0.00437	0.0111	CcSEcCtD
Lovastatin—Ill-defined disorder—Ramipril—type 1 diabetes mellitus	0.00432	0.011	CcSEcCtD
Lovastatin—ABCC2—nephron tubule—type 1 diabetes mellitus	0.00428	0.0208	CbGeAlD
Lovastatin—Angioedema—Ramipril—type 1 diabetes mellitus	0.00426	0.0108	CcSEcCtD
Lovastatin—Malaise—Ramipril—type 1 diabetes mellitus	0.0042	0.0107	CcSEcCtD
Lovastatin—Vertigo—Ramipril—type 1 diabetes mellitus	0.00419	0.0107	CcSEcCtD
Lovastatin—Leukopenia—Ramipril—type 1 diabetes mellitus	0.00417	0.0106	CcSEcCtD
Lovastatin—SLCO1A2—kidney—type 1 diabetes mellitus	0.00404	0.0196	CbGeAlD
Lovastatin—Arthralgia—Ramipril—type 1 diabetes mellitus	0.00397	0.0101	CcSEcCtD
Lovastatin—Myalgia—Ramipril—type 1 diabetes mellitus	0.00397	0.0101	CcSEcCtD
Lovastatin—Chest pain—Ramipril—type 1 diabetes mellitus	0.00397	0.0101	CcSEcCtD
Lovastatin—Anxiety—Ramipril—type 1 diabetes mellitus	0.00395	0.0101	CcSEcCtD
Lovastatin—Discomfort—Ramipril—type 1 diabetes mellitus	0.00392	0.00997	CcSEcCtD
Lovastatin—Dry mouth—Ramipril—type 1 diabetes mellitus	0.00388	0.00987	CcSEcCtD
Lovastatin—Confusional state—Ramipril—type 1 diabetes mellitus	0.00383	0.00976	CcSEcCtD
Lovastatin—Anaphylactic shock—Ramipril—type 1 diabetes mellitus	0.0038	0.00968	CcSEcCtD
Lovastatin—ABCC2—kidney—type 1 diabetes mellitus	0.00377	0.0183	CbGeAlD
Lovastatin—Thrombocytopenia—Ramipril—type 1 diabetes mellitus	0.00372	0.00947	CcSEcCtD
Lovastatin—Anorexia—Ramipril—type 1 diabetes mellitus	0.00363	0.00922	CcSEcCtD
Lovastatin—CYP3A5—islet of Langerhans—type 1 diabetes mellitus	0.0036	0.0175	CbGeAlD
Lovastatin—Musculoskeletal discomfort—Ramipril—type 1 diabetes mellitus	0.00346	0.00882	CcSEcCtD
Lovastatin—Insomnia—Ramipril—type 1 diabetes mellitus	0.00344	0.00875	CcSEcCtD
Lovastatin—Paraesthesia—Ramipril—type 1 diabetes mellitus	0.00341	0.00869	CcSEcCtD
Lovastatin—Dyspnoea—Ramipril—type 1 diabetes mellitus	0.00339	0.00863	CcSEcCtD
Lovastatin—Dyspepsia—Ramipril—type 1 diabetes mellitus	0.00335	0.00852	CcSEcCtD
Lovastatin—Decreased appetite—Ramipril—type 1 diabetes mellitus	0.00331	0.00841	CcSEcCtD
Lovastatin—Fatigue—Ramipril—type 1 diabetes mellitus	0.00328	0.00834	CcSEcCtD
Lovastatin—Constipation—Ramipril—type 1 diabetes mellitus	0.00325	0.00827	CcSEcCtD
Lovastatin—Feeling abnormal—Ramipril—type 1 diabetes mellitus	0.00313	0.00797	CcSEcCtD
Lovastatin—Gastrointestinal pain—Ramipril—type 1 diabetes mellitus	0.00311	0.00791	CcSEcCtD
Lovastatin—Urticaria—Ramipril—type 1 diabetes mellitus	0.00302	0.00769	CcSEcCtD
Lovastatin—Abdominal pain—Ramipril—type 1 diabetes mellitus	0.00301	0.00765	CcSEcCtD
Lovastatin—Body temperature increased—Ramipril—type 1 diabetes mellitus	0.00301	0.00765	CcSEcCtD
Lovastatin—CYP3A5—nephron tubule—type 1 diabetes mellitus	0.0029	0.0141	CbGeAlD
Lovastatin—CYP2C8—kidney—type 1 diabetes mellitus	0.00282	0.0137	CbGeAlD
Lovastatin—Hypersensitivity—Ramipril—type 1 diabetes mellitus	0.0028	0.00713	CcSEcCtD
Lovastatin—Asthenia—Ramipril—type 1 diabetes mellitus	0.00273	0.00694	CcSEcCtD
Lovastatin—Pruritus—Ramipril—type 1 diabetes mellitus	0.00269	0.00685	CcSEcCtD
Lovastatin—Diarrhoea—Ramipril—type 1 diabetes mellitus	0.0026	0.00662	CcSEcCtD
Lovastatin—CYP2C9—cardiovascular system—type 1 diabetes mellitus	0.00256	0.0124	CbGeAlD
Lovastatin—CYP3A5—kidney—type 1 diabetes mellitus	0.00255	0.0124	CbGeAlD
Lovastatin—CYP3A5—pancreas—type 1 diabetes mellitus	0.00253	0.0123	CbGeAlD
Lovastatin—Dizziness—Ramipril—type 1 diabetes mellitus	0.00251	0.0064	CcSEcCtD
Lovastatin—Vomiting—Ramipril—type 1 diabetes mellitus	0.00242	0.00615	CcSEcCtD
Lovastatin—Rash—Ramipril—type 1 diabetes mellitus	0.0024	0.0061	CcSEcCtD
Lovastatin—Dermatitis—Ramipril—type 1 diabetes mellitus	0.0024	0.0061	CcSEcCtD
Lovastatin—Headache—Ramipril—type 1 diabetes mellitus	0.00238	0.00606	CcSEcCtD
Lovastatin—Nausea—Ramipril—type 1 diabetes mellitus	0.00226	0.00575	CcSEcCtD
Lovastatin—ABCB1—islet of Langerhans—type 1 diabetes mellitus	0.00191	0.00928	CbGeAlD
Lovastatin—CYP3A4—kidney—type 1 diabetes mellitus	0.00191	0.00927	CbGeAlD
Lovastatin—CYP2D6—kidney—type 1 diabetes mellitus	0.00188	0.00912	CbGeAlD
Lovastatin—ABCB1—retina—type 1 diabetes mellitus	0.00164	0.00793	CbGeAlD
Lovastatin—ABCB1—nephron tubule—type 1 diabetes mellitus	0.00154	0.00747	CbGeAlD
Lovastatin—ABCB1—cardiovascular system—type 1 diabetes mellitus	0.00138	0.00671	CbGeAlD
Lovastatin—ABCB1—kidney—type 1 diabetes mellitus	0.00135	0.00656	CbGeAlD
Lovastatin—ABCB1—pancreas—type 1 diabetes mellitus	0.00135	0.00652	CbGeAlD
Lovastatin—ABCB1—lymphoid tissue—type 1 diabetes mellitus	0.00116	0.00564	CbGeAlD
Lovastatin—HDAC2—Hemostasis—NOS2—type 1 diabetes mellitus	0.000234	0.000585	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—HBA2—type 1 diabetes mellitus	0.000231	0.000576	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—STAT3—type 1 diabetes mellitus	0.000229	0.000572	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL1B—type 1 diabetes mellitus	0.000229	0.000571	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—CASP3—type 1 diabetes mellitus	0.000228	0.00057	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—IL2—type 1 diabetes mellitus	0.000228	0.000569	CbGpPWpGaD
Lovastatin—HDAC2—Disease—B2M—type 1 diabetes mellitus	0.000227	0.000566	CbGpPWpGaD
Lovastatin—CYP3A4—Biological oxidations—GSTT1—type 1 diabetes mellitus	0.000226	0.000565	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000224	0.000559	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000224	0.000558	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ABCC8—type 1 diabetes mellitus	0.000219	0.000546	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000217	0.000543	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—G6PC2—type 1 diabetes mellitus	0.000217	0.000541	CbGpPWpGaD
Lovastatin—SLCO1B1—SLC-mediated transmembrane transport—ALB—type 1 diabetes mellitus	0.000216	0.00054	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ITPR3—type 1 diabetes mellitus	0.000216	0.000539	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GAL—type 1 diabetes mellitus	0.000212	0.000529	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—STAT3—type 1 diabetes mellitus	0.000212	0.000529	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL20—type 1 diabetes mellitus	0.00021	0.000523	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCL11—type 1 diabetes mellitus	0.00021	0.000523	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—type 1 diabetes mellitus	0.000208	0.00052	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—EGFR—type 1 diabetes mellitus	0.000208	0.00052	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IGF1—type 1 diabetes mellitus	0.000208	0.000518	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000205	0.000511	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—HBA1—type 1 diabetes mellitus	0.000203	0.000507	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—APOC3—type 1 diabetes mellitus	0.000202	0.000504	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—type 1 diabetes mellitus	0.0002	0.000499	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GSTT1—type 1 diabetes mellitus	0.000198	0.000495	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CHRM2—type 1 diabetes mellitus	0.000197	0.000492	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—ALB—type 1 diabetes mellitus	0.000197	0.000491	CbGpPWpGaD
Lovastatin—HDAC2—Circadian rythm related genes—IL6—type 1 diabetes mellitus	0.000196	0.00049	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—GCG—type 1 diabetes mellitus	0.000194	0.000484	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—EGFR—type 1 diabetes mellitus	0.000193	0.000481	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS1—type 1 diabetes mellitus	0.00019	0.000475	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000189	0.000473	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—NOS3—type 1 diabetes mellitus	0.000188	0.00047	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ABCC8—type 1 diabetes mellitus	0.000188	0.000469	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000184	0.000458	CbGpPWpGaD
Lovastatin—HDAC2—Disease—PRKCQ—type 1 diabetes mellitus	0.000178	0.000444	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ITPR3—type 1 diabetes mellitus	0.000177	0.000442	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000177	0.000441	CbGpPWpGaD
Lovastatin—HDAC2—Disease—VAV1—type 1 diabetes mellitus	0.000173	0.000432	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—HBA1—type 1 diabetes mellitus	0.000173	0.000431	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—APOC3—type 1 diabetes mellitus	0.000172	0.000428	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—type 1 diabetes mellitus	0.00017	0.000424	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000169	0.000421	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC18A2—type 1 diabetes mellitus	0.000168	0.000418	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HBA2—type 1 diabetes mellitus	0.000167	0.000416	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SH2B3—type 1 diabetes mellitus	0.000167	0.000416	CbGpPWpGaD
Lovastatin—ABCB1—Allograft Rejection—TNF—type 1 diabetes mellitus	0.000166	0.000414	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IAPP—type 1 diabetes mellitus	0.000166	0.000413	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—APOC3—type 1 diabetes mellitus	0.000166	0.000413	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000165	0.000412	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—CAT—type 1 diabetes mellitus	0.000164	0.000409	CbGpPWpGaD
Lovastatin—HDAC2—Gene Expression—VDR—type 1 diabetes mellitus	0.000164	0.000409	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000162	0.000404	CbGpPWpGaD
Lovastatin—ITGAL—Immune System—IL6—type 1 diabetes mellitus	0.00016	0.000399	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ITPR3—type 1 diabetes mellitus	0.00016	0.000399	CbGpPWpGaD
Lovastatin—HDAC2—Hemostasis—IL2—type 1 diabetes mellitus	0.00016	0.000398	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—GCG—type 1 diabetes mellitus	0.000158	0.000394	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—G6PC2—type 1 diabetes mellitus	0.000157	0.000391	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—CP—type 1 diabetes mellitus	0.000154	0.000385	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—SLC11A1—type 1 diabetes mellitus	0.000153	0.000382	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD86—type 1 diabetes mellitus	0.000151	0.000376	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—HBA1—type 1 diabetes mellitus	0.00015	0.000375	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—APOC3—type 1 diabetes mellitus	0.000149	0.000373	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000149	0.000372	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000149	0.000371	CbGpPWpGaD
Lovastatin—HDAC2—Signaling by NGF—IL6—type 1 diabetes mellitus	0.000148	0.00037	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000147	0.000367	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GSTT1—type 1 diabetes mellitus	0.000147	0.000366	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—type 1 diabetes mellitus	0.000146	0.000365	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—SST—type 1 diabetes mellitus	0.000145	0.000363	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ADRB1—type 1 diabetes mellitus	0.000145	0.000361	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HBA2—type 1 diabetes mellitus	0.000144	0.00036	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—HBA1—type 1 diabetes mellitus	0.00014	0.00035	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—APOC3—type 1 diabetes mellitus	0.000139	0.000348	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000137	0.000342	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ITPR3—type 1 diabetes mellitus	0.000137	0.000341	CbGpPWpGaD
Lovastatin—HDAC2—Disease—ERBB3—type 1 diabetes mellitus	0.000136	0.000339	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ABCC8—type 1 diabetes mellitus	0.000136	0.000339	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—G6PC2—type 1 diabetes mellitus	0.000136	0.000339	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000135	0.000338	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—GCG—type 1 diabetes mellitus	0.000134	0.000335	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—APOC3—type 1 diabetes mellitus	0.000134	0.000335	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CCR5—type 1 diabetes mellitus	0.000134	0.000334	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—CAT—type 1 diabetes mellitus	0.000134	0.000334	CbGpPWpGaD
Lovastatin—HDAC2—Disease—HLA-A—type 1 diabetes mellitus	0.00013	0.000325	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—GCG—type 1 diabetes mellitus	0.00013	0.000323	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HBA2—type 1 diabetes mellitus	0.000129	0.000322	CbGpPWpGaD
Lovastatin—SLCO1A2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000129	0.000321	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—HBA1—type 1 diabetes mellitus	0.000129	0.000321	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—APOC3—type 1 diabetes mellitus	0.000128	0.000319	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HBA2—type 1 diabetes mellitus	0.000126	0.000314	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GSTT1—type 1 diabetes mellitus	0.000126	0.000313	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ITPR3—type 1 diabetes mellitus	0.000125	0.000313	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—PRKCQ—type 1 diabetes mellitus	0.000125	0.000311	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—G6PC2—type 1 diabetes mellitus	0.000121	0.000302	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—VAV1—type 1 diabetes mellitus	0.000121	0.000302	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CXCL10—type 1 diabetes mellitus	0.000121	0.000301	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HBA2—type 1 diabetes mellitus	0.000119	0.000296	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—G6PC2—type 1 diabetes mellitus	0.000118	0.000295	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—HBA1—type 1 diabetes mellitus	0.000118	0.000295	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ABCC8—type 1 diabetes mellitus	0.000118	0.000294	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HBA2—type 1 diabetes mellitus	0.000117	0.000293	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—APOC3—type 1 diabetes mellitus	0.000117	0.000293	CbGpPWpGaD
Lovastatin—ABCC2—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.000117	0.000292	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—GCG—type 1 diabetes mellitus	0.000117	0.000292	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	0.000116	0.000289	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GSTT1—type 1 diabetes mellitus	0.000115	0.000288	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—CAT—type 1 diabetes mellitus	0.000114	0.000284	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS2—type 1 diabetes mellitus	0.000113	0.000283	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—type 1 diabetes mellitus	0.000113	0.000281	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—G6PC2—type 1 diabetes mellitus	0.000111	0.000278	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—G6PC2—type 1 diabetes mellitus	0.00011	0.000276	CbGpPWpGaD
Lovastatin—SLCO1B1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	0.00011	0.000275	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD80—type 1 diabetes mellitus	0.00011	0.000275	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF2—type 1 diabetes mellitus	0.00011	0.000274	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—GCG—type 1 diabetes mellitus	0.000109	0.000272	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—INS—type 1 diabetes mellitus	0.000109	0.000272	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—KCNJ11—type 1 diabetes mellitus	0.000107	0.000268	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD86—type 1 diabetes mellitus	0.000106	0.000264	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ABCC8—type 1 diabetes mellitus	0.000105	0.000262	CbGpPWpGaD
Lovastatin—HDAC2—Disease—INS—type 1 diabetes mellitus	0.000104	0.000259	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ABCC8—type 1 diabetes mellitus	0.000103	0.000256	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—E2F1—type 1 diabetes mellitus	0.0001	0.00025	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—GCG—type 1 diabetes mellitus	0.0001	0.00025	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—ALB—type 1 diabetes mellitus	9.98e-05	0.000249	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—CAT—type 1 diabetes mellitus	9.9e-05	0.000247	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ABCC8—type 1 diabetes mellitus	9.66e-05	0.000241	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ABCC8—type 1 diabetes mellitus	9.58e-05	0.000239	CbGpPWpGaD
Lovastatin—HMGCR—Metabolism—NOS3—type 1 diabetes mellitus	9.55e-05	0.000238	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—ERBB3—type 1 diabetes mellitus	9.52e-05	0.000238	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CCR5—type 1 diabetes mellitus	9.37e-05	0.000234	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—KCNJ11—type 1 diabetes mellitus	9.3e-05	0.000232	CbGpPWpGaD
Lovastatin—HDAC2—Disease—TYK2—type 1 diabetes mellitus	9.29e-05	0.000232	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—CAT—type 1 diabetes mellitus	9.24e-05	0.000231	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2RA—type 1 diabetes mellitus	9.23e-05	0.00023	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—GCG—type 1 diabetes mellitus	9.18e-05	0.000229	CbGpPWpGaD
Lovastatin—HDAC2—Disease—NOS3—type 1 diabetes mellitus	9.12e-05	0.000228	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ITPR3—type 1 diabetes mellitus	9.07e-05	0.000226	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—INS—type 1 diabetes mellitus	8.88e-05	0.000222	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—type 1 diabetes mellitus	8.6e-05	0.000215	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—HBA1—type 1 diabetes mellitus	8.53e-05	0.000213	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—APOC3—type 1 diabetes mellitus	8.48e-05	0.000212	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—CAT—type 1 diabetes mellitus	8.47e-05	0.000211	CbGpPWpGaD
Lovastatin—HDAC2—Disease—CD4—type 1 diabetes mellitus	8.4e-05	0.00021	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GSTT1—type 1 diabetes mellitus	8.33e-05	0.000208	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—KCNJ11—type 1 diabetes mellitus	8.3e-05	0.000207	CbGpPWpGaD
Lovastatin—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—type 1 diabetes mellitus	8.19e-05	0.000204	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—ALB—type 1 diabetes mellitus	8.14e-05	0.000203	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—KCNJ11—type 1 diabetes mellitus	8.1e-05	0.000202	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ITPR3—type 1 diabetes mellitus	7.85e-05	0.000196	CbGpPWpGaD
Lovastatin—UGT1A3—Metabolism—NOS3—type 1 diabetes mellitus	7.78e-05	0.000194	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—CAT—type 1 diabetes mellitus	7.77e-05	0.000194	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HBA2—type 1 diabetes mellitus	7.75e-05	0.000193	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CD80—type 1 diabetes mellitus	7.7e-05	0.000192	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—KCNJ11—type 1 diabetes mellitus	7.64e-05	0.000191	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—KCNJ11—type 1 diabetes mellitus	7.57e-05	0.000189	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—INS—type 1 diabetes mellitus	7.55e-05	0.000188	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—HBA1—type 1 diabetes mellitus	7.39e-05	0.000184	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—APOC3—type 1 diabetes mellitus	7.34e-05	0.000183	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—G6PC2—type 1 diabetes mellitus	7.29e-05	0.000182	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—INS—type 1 diabetes mellitus	7.28e-05	0.000182	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GSTT1—type 1 diabetes mellitus	7.21e-05	0.00018	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IGF1—type 1 diabetes mellitus	7.04e-05	0.000176	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ITPR3—type 1 diabetes mellitus	7.01e-05	0.000175	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—ALB—type 1 diabetes mellitus	6.92e-05	0.000173	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ITPR3—type 1 diabetes mellitus	6.84e-05	0.000171	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	6.65e-05	0.000166	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—GCG—type 1 diabetes mellitus	6.64e-05	0.000166	CbGpPWpGaD
Lovastatin—UGT2B7—Metabolism—NOS3—type 1 diabetes mellitus	6.62e-05	0.000165	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—HBA1—type 1 diabetes mellitus	6.6e-05	0.000165	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—INS—type 1 diabetes mellitus	6.57e-05	0.000164	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—APOC3—type 1 diabetes mellitus	6.56e-05	0.000164	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—TYK2—type 1 diabetes mellitus	6.5e-05	0.000162	CbGpPWpGaD
Lovastatin—HDAC2—Disease—STAT3—type 1 diabetes mellitus	6.5e-05	0.000162	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ITPR3—type 1 diabetes mellitus	6.45e-05	0.000161	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—HBA1—type 1 diabetes mellitus	6.44e-05	0.000161	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GSTT1—type 1 diabetes mellitus	6.44e-05	0.000161	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—APOC3—type 1 diabetes mellitus	6.4e-05	0.00016	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ITPR3—type 1 diabetes mellitus	6.39e-05	0.00016	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—NOS3—type 1 diabetes mellitus	6.38e-05	0.000159	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ABCC8—type 1 diabetes mellitus	6.32e-05	0.000158	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GSTT1—type 1 diabetes mellitus	6.28e-05	0.000157	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—INS—type 1 diabetes mellitus	6.13e-05	0.000153	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—HBA1—type 1 diabetes mellitus	6.07e-05	0.000151	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—APOC3—type 1 diabetes mellitus	6.03e-05	0.00015	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—ALB—type 1 diabetes mellitus	6.03e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—HBA1—type 1 diabetes mellitus	6.01e-05	0.00015	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—APOC3—type 1 diabetes mellitus	5.98e-05	0.000149	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.93e-05	0.000148	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GSTT1—type 1 diabetes mellitus	5.92e-05	0.000148	CbGpPWpGaD
Lovastatin—HDAC2—Disease—EGFR—type 1 diabetes mellitus	5.91e-05	0.000148	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GSTT1—type 1 diabetes mellitus	5.87e-05	0.000147	CbGpPWpGaD
Lovastatin—SLCO1A2—Metabolism—NOS3—type 1 diabetes mellitus	5.76e-05	0.000144	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—GCG—type 1 diabetes mellitus	5.75e-05	0.000143	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—ALB—type 1 diabetes mellitus	5.62e-05	0.00014	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—INS—type 1 diabetes mellitus	5.62e-05	0.00014	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—CAT—type 1 diabetes mellitus	5.62e-05	0.00014	CbGpPWpGaD
Lovastatin—ABCB1—Transmembrane transport of small molecules—ALB—type 1 diabetes mellitus	5.51e-05	0.000137	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—CASP3—type 1 diabetes mellitus	5.42e-05	0.000135	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL2—type 1 diabetes mellitus	5.41e-05	0.000135	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism of lipids and lipoproteins—ALB—type 1 diabetes mellitus	5.41e-05	0.000135	CbGpPWpGaD
Lovastatin—UGT1A1—Metabolism—NOS3—type 1 diabetes mellitus	5.38e-05	0.000134	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—INS—type 1 diabetes mellitus	5.16e-05	0.000129	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—ALB—type 1 diabetes mellitus	5.15e-05	0.000129	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—GCG—type 1 diabetes mellitus	5.13e-05	0.000128	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—GCG—type 1 diabetes mellitus	5.01e-05	0.000125	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—KCNJ11—type 1 diabetes mellitus	4.99e-05	0.000125	CbGpPWpGaD
Lovastatin—SLCO1B1—Metabolism—NOS3—type 1 diabetes mellitus	4.93e-05	0.000123	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—CAT—type 1 diabetes mellitus	4.87e-05	0.000121	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—ALB—type 1 diabetes mellitus	4.73e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—GCG—type 1 diabetes mellitus	4.72e-05	0.000118	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—GCG—type 1 diabetes mellitus	4.68e-05	0.000117	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—STAT3—type 1 diabetes mellitus	4.55e-05	0.000114	CbGpPWpGaD
Lovastatin—HDAC2—Disease—IL6—type 1 diabetes mellitus	4.54e-05	0.000113	CbGpPWpGaD
Lovastatin—CYP3A7—Metabolism—NOS3—type 1 diabetes mellitus	4.52e-05	0.000113	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—CAT—type 1 diabetes mellitus	4.34e-05	0.000108	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—CAT—type 1 diabetes mellitus	4.24e-05	0.000106	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ITPR3—type 1 diabetes mellitus	4.21e-05	0.000105	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—EGFR—type 1 diabetes mellitus	4.14e-05	0.000103	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—CAT—type 1 diabetes mellitus	3.99e-05	9.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—HBA1—type 1 diabetes mellitus	3.97e-05	9.9e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—CAT—type 1 diabetes mellitus	3.96e-05	9.88e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—APOC3—type 1 diabetes mellitus	3.94e-05	9.84e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GSTT1—type 1 diabetes mellitus	3.87e-05	9.66e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—INS—type 1 diabetes mellitus	3.73e-05	9.31e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—ALB—type 1 diabetes mellitus	3.42e-05	8.53e-05	CbGpPWpGaD
Lovastatin—CYP3A5—Metabolism—NOS3—type 1 diabetes mellitus	3.27e-05	8.16e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—INS—type 1 diabetes mellitus	3.23e-05	8.06e-05	CbGpPWpGaD
Lovastatin—HDAC2—Signaling Pathways—IL6—type 1 diabetes mellitus	3.18e-05	7.94e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—GCG—type 1 diabetes mellitus	3.08e-05	7.7e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—ALB—type 1 diabetes mellitus	2.96e-05	7.39e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—INS—type 1 diabetes mellitus	2.88e-05	7.19e-05	CbGpPWpGaD
Lovastatin—CYP2C8—Metabolism—NOS3—type 1 diabetes mellitus	2.83e-05	7.07e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—INS—type 1 diabetes mellitus	2.81e-05	7.02e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—INS—type 1 diabetes mellitus	2.65e-05	6.62e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—ALB—type 1 diabetes mellitus	2.64e-05	6.6e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—INS—type 1 diabetes mellitus	2.63e-05	6.56e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—CAT—type 1 diabetes mellitus	2.61e-05	6.52e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—ALB—type 1 diabetes mellitus	2.58e-05	6.44e-05	CbGpPWpGaD
Lovastatin—CYP2C19—Metabolism—NOS3—type 1 diabetes mellitus	2.53e-05	6.31e-05	CbGpPWpGaD
Lovastatin—ABCB1—Metabolism—NOS3—type 1 diabetes mellitus	2.47e-05	6.16e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—ALB—type 1 diabetes mellitus	2.43e-05	6.07e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—ALB—type 1 diabetes mellitus	2.41e-05	6.01e-05	CbGpPWpGaD
Lovastatin—CYP2D6—Metabolism—NOS3—type 1 diabetes mellitus	2.33e-05	5.8e-05	CbGpPWpGaD
Lovastatin—CYP2C9—Metabolism—NOS3—type 1 diabetes mellitus	2.31e-05	5.75e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—INS—type 1 diabetes mellitus	1.73e-05	4.33e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—ALB—type 1 diabetes mellitus	1.59e-05	3.97e-05	CbGpPWpGaD
Lovastatin—CYP3A4—Metabolism—NOS3—type 1 diabetes mellitus	1.52e-05	3.79e-05	CbGpPWpGaD
